A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Mesothelioma
  • Pleural Neoplasms

abstract

  • This short but aggressive combined modality regimen was generally well tolerated, but should not be used outside of a protocol setting because of the potential for serious toxicity. Overall survival was as good or better than with previously reported multimodality approaches, but other strategies are needed to improve local control.

publication date

  • June 1994

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 8201377

Additional Document Info

start page

  • 1156

end page

  • 63

volume

  • 12

number

  • 6